Cell Stem Cell
Volume 23, Issue 2, 2 August 2018, Pages 181-192.e5
ArticleHuman iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Under an Elsevier user license
open archive
Graphical Abstract
Keywords
natural killer cells
chimeric antigen receptors
iPSCs
immunotherapy
ovarian cancer
Cited by (0)
© 2018 Elsevier Inc.